Journal
CURRENT CANCER DRUG TARGETS
Volume 18, Issue 3, Pages 256-265Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009617666170522094730
Keywords
DEK; cancer; gene regulations; biologic roles; diagnostic marker; drug target
Categories
Ask authors/readers for more resources
The DNA binding protein and chromatin structural regulator DEK regulate many cellular processes. These include proliferation, differentiation, apoptosis, senescence, DNA repairing and the maintenance of stem cell phenotype. DEK is increasingly recognized as a crucial player in many steps of cancer initiation and progression, and is precisely regulated by abundant promoting and inhibiting factors directly or indirectly. DEK may serve as an architectural modulating protein to regulate the expression and function of multiple human genes in cancer cells. In this article we have reviewed the specificities and complexities of DEK in the regulation of transcription factors and global chromatin, including its biologic roles in malignant cells, and summarized the current research. The possible use of DEK as a diagnostic marker and drug target in the prevention or treatment of tumors is also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available